These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15121132)

  • 21. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.
    Rosenfeld WE; Sachdeo RC; Faught RE; Privitera M
    Epilepsia; 1997; 38 Suppl 1():S34-6. PubMed ID: 9092957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study.
    Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI
    Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate loading for refractory status epilepticus in children.
    Perry MS; Holt PJ; Sladky JT
    Epilepsia; 2006 Jun; 47(6):1070-1. PubMed ID: 16822255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of topiramate in eleven patients with Dravet syndrome].
    Takahashi H; Takahashi Y; Mine J; Mukaida S; Ikegami M; Ikeda H; Ohtani H; Shimomura J; Kubota Y; Fujiwara T
    No To Hattatsu; 2010 Jul; 42(4):273-6. PubMed ID: 20666132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.
    Reife RA; Pledger GW
    Epilepsia; 1997; 38 Suppl 1():S31-3. PubMed ID: 9092956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy.
    Placidi F; Tombini M; Romigi A; Bianchi L; Izzi F; Sperli F; Mattia D; Cervellino A; Marciani MG
    Epilepsy Res; 2004 Jan; 58(1):43-52. PubMed ID: 15066674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Topiramate in clinical practice (part 1). Multicentric retrospective analysis of the efficacy of topiramate as add-on therapy according to the topographic form of focal epilepsy].
    Biraben A; Genton P
    Rev Neurol (Paris); 2000 Nov; 156(11):993-9. PubMed ID: 11119051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drugs trials: neonates and infants.
    Pellock J
    Epilepsy Res; 2006 Jan; 68(1):42-5. PubMed ID: 16377140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
    Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
    Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
    Chung SS; Fakhoury TA; Hogan RE; Nagaraddi VN; Blatt I; Lawson B; Arnold S; Anders B; Clark AM; Laine D; Meadows RS; Halvorsen MB;
    Epilepsia; 2014 Jul; 55(7):1077-87. PubMed ID: 24902983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly.
    Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX
    J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance.
    Hogan RE; Blatt I; Lawson B; Nagaraddi V; Fakhoury TA; Anders B; Clark AM; Laine D; Halvorsen MB; Chung SS
    Epilepsy Behav; 2014 Dec; 41():136-9. PubMed ID: 25461205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
    Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A
    Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents.
    Ben-Menachem E
    Epilepsia; 1996; 37 Suppl 2():S4-S7. PubMed ID: 8641244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate on ictal seizure semiology: a quantitative, randomized, low and medium dose-controlled study.
    Wang Y; Zhou D; Pauli E; Stefan H
    Epilepsy Res; 2001 Sep; 46(3):271-7. PubMed ID: 11518628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Topiramate--an effective new anticonvulsant. An open prospective study].
    Bittermann HJ; Steinhoff BJ
    Nervenarzt; 1997 Oct; 68(10):836-8. PubMed ID: 9441257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of topiramate for patients with intractable epilepsy].
    Matsuo M; Matsuzaka T
    No To Hattatsu; 2012 Jul; 44(4):300-4. PubMed ID: 22844761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate: a new safe and effective antiepileptic.
    Gupta M; Rehman N; Bansal J; Mogre V
    J Indian Med Assoc; 2001 Aug; 99(8):449-50. PubMed ID: 11881861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.